Prospective study of circulating microRNAs for the prediction of the onset of rheumatoid arthritis
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000007043
- Lead Sponsor
- Kyoto Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who were previously diagnosed as rheumatoid arthritis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fulfillment of 1987 ACR revised criteria for the classification of RA or the 2010 ACR/EULAR classification criteria for RA
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways do circulating miRNAs target in rheumatoid arthritis progression?
How effective are circulating miRNAs compared to traditional biomarkers in predicting RA onset?
Which specific circulating miRNAs are most predictive of rheumatoid arthritis onset in high-risk populations?
What are the potential false positive rates of miRNA-based RA prediction models and how are they managed?
Are miRNA inhibitors or modulators being explored as therapeutic strategies for rheumatoid arthritis in combination with existing DMARDs?